The Securities and Exchange Commission (SEC) recently announced that fiscal year (FY) 2022 was the second highest in both the number and dollar amount of awards in the history of its whistleblower program. The Commission issued 103 awards totaling $229 million to whistleblowers during the fiscal year which ended on September 30, 2021. These results...
U.S. District Court for the District of Massachusetts Refuses to Adopt Narrow Definition of SEC Whistleblower Under Dodd-Frank On October 16, 2013, a federal court in Massachusetts issued a ruling widely applauded by whistleblower attorneys and advocates. See Ellington v. Giacoumakis, No. 13-11791-RGS, 2013 WL 5631046 (D. Mass. Oct. 16, 2013). The primary issue in the decision...
On Thursday November 3, 2011, the drug firm GlaxoSmithKline finally agreed to pay a $3 billion settlement to the United States government over allegations that the company continued to practice illegal marketing tactics for their diabetes drug Avandia, which was recently restricted due to the risks it posed to the heart. According to whistleblowers within...
Denver Health & Hospital Authority to Pay $6.2 Million Philadelphia, PA, January 5, 2012 – Egan Young, Attorneys-at-Law, is pleased to announce that Denver Health and Hospital Authority (“DHHA”) has agreed to pay $6.3 million to settle allegations that the DHHA submitted false claims to Medicare and Medicaid by improperly submitting claims for short hospital...
Denver Health & Hospital Authority to Pay $6.2 Million to Settle Claims that it Overbilled Medicare and Medicaid Philadelphia, PA, January 5, 2012– Egan Young, Attorneys-at-Law, is pleased to announce that Denver Health and Hospital Authority (“DHHA”) has agreed to pay $6.3 million to settle allegations that the DHHA submitted false claims to Medicare and Medicaid...





